Colorectal Cancer Diagnostics Market
Medical Device

Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Mayur SComments Off on Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Medtronic Plc and Boston Scientific Corporation – Notable Market Players in Colorectal Cancer Diagnostics Market

Key driving factors include the factors driving the colorectal cancer diagnostics market growth are increasing prevalence of colorectal cancer and launches of new products. However, the low accuracy of screening based on fecal immunochemical tests (FITs)hinders the colorectal cancer diagnostics market growth. 

The colorectal cancer diagnostics market is majorly comprised of top players involving Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd. among others.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the colorectal cancer diagnostics market:       

Year

News

March 2023

Sengkang General Hospital collaborate with Medtronic promote AI-assisted colonoscopies.
The two organizations have signed a memorandum of understanding to promote AI-assisted colonoscopy
for colorectal cancer screening.

August 2021

Illumina Acquired GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test.
GRAIL’s Galleri blood test detects 50 different cancers before they are symptomatic. Illumina’s acquisition of
GRAIL will accelerate access and adoption of this life-saving test worldwide.

January 2020

Illumina, Roche Launched NGS-Based Cancer Diagnostics Partnership. Illumina and Roche have
signed a 15-year, non-exclusive collaboration agreement designed to realize next-generation
sequencing’s potential to transform cancer risk prediction, detection, diagnosis, treatment, and monitoring.

April 2020

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics for Innovative First-Line Colorectal Cancer Screening Blood Test.
The alliance also expands the company’s commercialization rights for hte Trident Program and COLVERA for CRC monitoring outside the US,
Mexico, UK, and India.

 

Mayur S
https://www.theinsightpartners.com/

Related Articles

Full Body Scanner Market
Medical Device

Asia Pacific Point-of-Care Molecular Diagnostics Market to Grow at CAGR of 14.0% to reach US$ 1,251.7 million by 2028

The Insight Partners

Point-of-care testing (POCT) is essential for the rapid detection facilitating better disease diagnosis, monitoring, and management. It is highly specialized for quick medical decisions, as the diseases can be diagnosed at early stage, resulting for improving health outcomes for patients by enabling the early start of treatment. HOFFMANN-LA ROCHE LTD. and Abbott Laboratories. – Notable […]

Cannabis Testing
Medical Device

Cannabis Testing Market Rising Application Innovations with 10.1% of CAGR by 2028.

The Insight Partners

Cannabis testing is used in variety of applications that includes determining the concentration of cannabis in various analytical samples such as pharmaceutical drugs, and detection of contaminants such as bacteria and fungi. It is very crucial to test the cannabis products used for medicinal purposes in order to avoid side effects. Furthermore, the cannabis testing […]

PCR for Respiratory Infection Diagnostic Market
Medical Device

PCR for Respiratory Infection Diagnostic Market is emerging with 10.4% CAGR by 2028.

The Insight Partners

Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years. Leading players operating in the PCR for Respiratory Infection […]